California CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Vacaville Unveils Plans for 300-Acre Biotech Development
The City of Vacaville plans to develop California Biomanufacturing Center, a 300-acre biomanufacturing cluster. The city expects that this expansion will lead to more than $2 billion in industrial development, 3.5 million square feet of commercial real estate, and the addition of 10,000 jobs with a payroll of more than $1 billion a year. The expanded cluster will be built on a site that’s adjacent to existing facilities.
Vacaville Mayor Ron Rowlett says, “Vacaville has the land, infrastructure, and workforce that the biotechnology industry needs to grow, as well as a long-standing commitment to make doing so a streamlined and efficient process.”
The city also created the California Biomanufacturing Center, Inc., a nonprofit that will accelerate the growth of the sector in Vacaville by working with industry and academic partners. A center for biomanufacturing since the 1980s, Vacaville gained recognition as a world-class biotechnology center in 1994, when Genentech acquired land for its biologics manufacturing facility, which is among the largest biotech drug manufacturing complexes in the world.
For comments, questions or concerns, please contact Dennis Kaiser
- ◦Development
